Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
ERBB3 expression
i
Other names:
ERBB3, HER3, LCCS2, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
Associations
(23)
News
Trials
B | Sensitive
C2 | Sensitive
C3 | Sensitive
D | Sensitive
B | Resistant
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Chemotherapy
Tyrosine Kinase Inhibitors
Immunotherapy
EGFR
Other
CD Protein Inhibitors
Kinase Inhibitors
Cancel
Colorectal Cancer
HER2 Positive Breast Cancer
Breast Cancer
Renal Cell Carcinoma
Prostate Cancer
Ovarian Cancer
Lung Cancer
Estrogen Receptor Positive Breast Cancer
Solid Tumor
Endometrial Cancer
Bladder Cancer
Melanoma
Pancreatic Cancer
ado-trastuzumab emtansine
B
ERBB3 expression
|
HER2 Positive Breast Cancer
|
ado-trastuzumab emtansine
U3-1402
C2
ERBB3 expression
|
Colorectal Cancer
|
U3-1402
C2
ERBB3 expression
|
Breast Cancer
|
U3-1402
D
ERBB3 expression
|
Estrogen Receptor Positive Breast Cancer
|
U3-1402
D
ERBB3 expression
|
Melanoma
|
U3-1402
cetuximab
C3
ERBB3 expression
|
Colorectal Cancer
|
cetuximab
Ac-225 ErbB3 targeted radiotherapy
D
ERBB3 expression
|
Colorectal Cancer
|
Ac-225 ErbB3 targeted radiotherapy
D
ERBB3 expression
|
Renal Cell Carcinoma
|
Ac-225 ErbB3 targeted radiotherapy
D
ERBB3 expression
|
Prostate Cancer
|
Ac-225 ErbB3 targeted radiotherapy
D
ERBB3 expression
|
Ovarian Cancer
|
Ac-225 ErbB3 targeted radiotherapy
177Lu-satetraxetan-lilotomab
D
ERBB3 expression
|
Colorectal Cancer
|
177Lu-satetraxetan-lilotomab
D
ERBB3 expression
|
Renal Cell Carcinoma
|
177Lu-satetraxetan-lilotomab
D
ERBB3 expression
|
Prostate Cancer
|
177Lu-satetraxetan-lilotomab
D
ERBB3 expression
|
Ovarian Cancer
|
177Lu-satetraxetan-lilotomab
DB-1310
D
ERBB3 expression
|
Breast Cancer
|
DB-1310
D
ERBB3 expression
|
Lung Cancer
|
DB-1310
U3-1402 + BAY 1895344
D
ERBB3 expression
|
Estrogen Receptor Positive Breast Cancer
|
U3-1402 + BAY 1895344
HMBD-501
D
ERBB3 expression
|
Solid Tumor
|
HMBD-501
AMT-562
D
ERBB3 expression
|
Lung Cancer
|
AMT-562
lapatinib
D
ERBB3 expression
|
Endometrial Cancer
|
lapatinib
D
ERBB3 expression
|
Bladder Cancer
|
lapatinib
afatinib
D
ERBB3 expression
|
Pancreatic Cancer
|
afatinib
pertuzumab
D
ERBB3 expression
|
Pancreatic Cancer
|
pertuzumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
